VANTOBRA sol inhal 170 mg/1.7ml amp 56 pce

7680685390011 CH-68539 J01GB01 08.01.7.
VANTOBRA sol inhal 170 mg/1.7ml amp 56 pce
VANTOBRA sol inhal 170 mg/1.7ml amp 56 pce
VANTOBRA sol inhal 170 mg/1.7ml amp 56 pce
1 / 3
google

Details

Product number
6853901
CPT
-
Packaging group
56
Unit
Ampulle(n)
Composition
tobramycinum 170 mg, natrii chloridum, calcii chloridum dihydricum, magnesii sulfas heptahydricus, acidum sulfuricum, natrii hydroxidum, aqua ad iniectabile ad solutionem pro 1.7 ml.

Articles (1)

Vantobra 170 mg, Lösung für einen Vernebler
Lösung
56
View

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
19/01/2024
Patient information leaflet
Français
19/01/2024
Patient information leaflet
Italien
19/01/2024
Professional SmPC
Allemand
19/01/2024
Professional SmPC
Français
19/01/2024
Professional SmPC
Italien
19/01/2024

Detailed composition

Substance Quantity Type Category
(N/A)
170.0 MG Substance Wirkstoff (Principe actif)
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK

Reimbursement information

Public price
CHF 2236.60
Specialties list
Yes
Generic
No
SL addition date: 01/05/2023

Authorization holder

PARI Swiss AG

6330 Cham

Authorization information

Swissmedic authorization number
68539
Drug name
Vantobra, Lösung für einen Vernebler
Galenic form
LSVE
ATC Code
J01GB01
Authorization status
Z
Dispensation category
A
First authorization
11/10/2022
Authorization expiration date
10/10/2027
IT number
08.01.7.
Domain
Human medicine
Field of application
Chronische Infektion der Lunge mit Pseudomonas aeruginosa bei Patienten mit Mukoviszidose

Packaging details

Description (FR)
VANTOBRA sol inhal 170 mg/1.7ml amp 56 pce
Description (DE)
VANTOBRA Inhal Lös 170 mg/1.7ml Amp 56 Stk
Market launch
11/10/2022
Narcotic (BTM)
No